Michelle G. Davis

833 total citations
9 papers, 652 citations indexed

About

Michelle G. Davis is a scholar working on Epidemiology, Oncology and Infectious Diseases. According to data from OpenAlex, Michelle G. Davis has authored 9 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Oncology and 2 papers in Infectious Diseases. Recurrent topics in Michelle G. Davis's work include Cytomegalovirus and herpesvirus research (7 papers), Viral-associated cancers and disorders (6 papers) and Herpesvirus Infections and Treatments (4 papers). Michelle G. Davis is often cited by papers focused on Cytomegalovirus and herpesvirus research (7 papers), Viral-associated cancers and disorders (6 papers) and Herpesvirus Infections and Treatments (4 papers). Michelle G. Davis collaborates with scholars based in United States, Poland and Slovakia. Michelle G. Davis's co-authors include Karen K. Biron, Leroy B. Townsend, John C. Drach, Wayne H. Miller, Christine L. Talarico, Sylvia C. Stanat, Robert G. Ferris, George W. Koszalka, Ronna E. Dornsife and Richard J. Harvey and has published in prestigious journals such as Journal of Virology, Journal of Bacteriology and The Journal of Infectious Diseases.

In The Last Decade

Michelle G. Davis

9 papers receiving 623 citations

Peers

Countries citing papers authored by Michelle G. Davis

Since Specialization

Citations

This map shows the geographic impact of Michelle G. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle G. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle G. Davis more than expected).

Fields of papers citing papers by Michelle G. Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle G. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle G. Davis. The network helps show where Michelle G. Davis may publish in the future.

Co-authorship network of co-authors of Michelle G. Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle G. Davis. A scholar is included among the top collaborators of Michelle G. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle G. Davis. Michelle G. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	Mutations in the Human Cytomegalovirus UL27 Gene That Confer Resistance to Maribavir 2004 ·Journal of Virology ·Sunwen Chou, Gail I. Marousek, (unknown), Michelle G. Davis, Karen K. Biron	62
2	Mechanism of Action of the Ribopyranoside Benzimidazole GW275175X against Human Cytomegalovirus 2004 ·Antimicrobial Agents and Chemotherapy ·Mark Underwood, Robert G. Ferris, Dean W. Selleseth, Michelle G. Davis, John C. Drach, Leroy B. Townsend, Karen K. Biron, F. Leslie Boyd	41
3	Elevated Virus Loads of Kaposi’s Sarcoma–Associated Human Herpesvirus 8 Predict Kaposi's Sarcoma Disease Progression, but Elevated Levels of Human Immunodeficiency Virus Type 1 Do Not 2002 ·The Journal of Infectious Diseases ·E. Byrd Quinlivan, Chuan Zhang, Paul W. Stewart, Chulaluk Komoltri, Michelle G. Davis, Robert S. Wehbie	64
4	Potent and Selective Inhibition of Human Cytomegalovirus Replication by 1263W94, a Benzimidazole l -Riboside with a Unique Mode of Action 2002 ·Antimicrobial Agents and Chemotherapy ·Karen K. Biron, Richard J. Harvey, (unknown), Steven S. Good, Albert A. Smith, Michelle G. Davis, Christine L. Talarico, Wayne H. Miller, Robert G. Ferris, Ronna E. Dornsife, Sylvia C. Stanat, John C. Drach, Leroy B. Townsend, George W. Koszalka	295
5	Phosphorylation of β-d-Ribosylbenzimidazoles Is Not Required for Activity against Human Cytomegalovirus 2002 ·Antimicrobial Agents and Chemotherapy ·Paula M. Krosky, Katherine Z. Borysko, Mahmoud Nassiri, Rodrigo V. Devivar, Roger G. Ptak, Michelle G. Davis, Karen K. Biron, Leroy B. Townsend, John C. Drach	28
6	Synthesis and Evaluation of a Series of 2′-Deoxy Analogues of The Antiviral Agent 5,6-Dichloro-2-Isopropylamino-1-(β-L-Ribofuranosyl)-1H-Benzimidazole (1263W94) 2000 ·Nucleosides Nucleotides & Nucleic Acids ·Joseph H. Chan, Stanley D. Chamberlain, Karen K. Biron, Michelle G. Davis, Richard J. Harvey, Dean W. Selleseth, Ronna E. Dornsife, (unknown), Lloyd Frick, Leroy B. Townsend, John C. Drach, George W. Koszalka	7
7	Inhibition of Epstein-Barr Virus Replication by a Benzimidazole l -Riboside: Novel Antiviral Mechanism of 5,6-Dichloro-2-(Isopropylamino)-1-β- l -Ribofuranosyl-1H-Benzimidazole 1999 ·Journal of Virology ·Valerie Zacny, Edward Gershburg, Michelle G. Davis, Karen K. Biron, Joseph S. Pagano	60
8	Acyclovir Is Phosphorylated by the Human Cytomegalovirus UL97 Protein 1999 ·Antimicrobial Agents and Chemotherapy ·Christine L. Talarico, Thimysta C. Burnette, Wayne H. Miller, Sheila L. Smith, Michelle G. Davis, Sylvia C. Stanat, Teresa I. Ng, (unknown), Donald M. Coen, Bernard Roizman, Karen K. Biron	77
9	Relationship Between Messenger Ribonucleic Acid and Enzyme Levels Specified by the Leucine Operon of Escherichia coli K-12 1977 ·Journal of Bacteriology ·Michelle G. Davis, Joseph M. Calvo	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact